Precision NanoSystems
402 - 6190 Agronomy Road
Vancouver
British Columbia
V6T 1Z3
Canada
Tel: 1-888-618-0031
Website: https://www.precisionnanosystems.com
About Precision NanoSystems
Precision NanoSystems, Inc. (PNI) creates innovative solutions for the discovery, development and manufacture of novel nanoparticles for use as medicines and in medical research. PNI's proprietary NanoAssemblr platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology.YEAR FOUNDED:
2010
LEADERSHIP:
CEO: James Taylor, PhD
COO: Euan Ramsay, PhD
26 articles about Precision NanoSystems
-
Precision NanoSystems and Replicate Bioscience in licensing deal to scale up genomic medicines
7/26/2022
Companies aim to support development of up to 15 new genomic medicine products.
-
August has been busy with a flurry of life sciences expansion announcements, particularly in the United States and Canada. Here’s a look at a few companies increasing their presence in the two countries.
-
Precision NanoSystems sets time and place to open new Genetic Medicine GMP Biomanufacturing Centre in Vancouver, BC
8/11/2021
Precision NanoSystems, a global leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently under construction.
-
Precision NanoSystems Announces New Cell Therapy Reagent for Lipid Nanoparticle -based mRNA Delivery to T Cells
4/20/2021
Precision NanoSystems (PNI) , a global leader in innovative solutions for genetic medicine development, today launched the GenVoy-ILM™ T Cell Kit for mRNA to enable lipid nanoparticle (LNP)-based ex vivo gene transfer.
-
Precision NanoSystems Receives Contribution from the Government of Canada to Build RNA Medicine Biomanufacturing Centre
2/2/2021
Investment will bring Canada's first centre of manufacturing excellence of nanomedicine-based RNA vaccines, gene therapies and cell therapies. At project completion early in 2023, the approximately 40,000 square foot leased bio-manufacturing facility will have multiple GMP suites with manufacturing lines for the end-to-end manufacturing of genetic medicines.
-
Precision NanoSystems Receives $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19
10/23/2020
Precision Nanosystems, Inc. (PNI), a global leader in technologies and solutions in genetic medicine, announced today that it has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and Economic Development's (ISED) Strategic Innovation Fund (SIF) to develop a COVID-19 vaccine.
-
Canada's Prime Minister, Justin Trudeau, Announced Today Precision NanoSystems Will Receive $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19
10/23/2020
Precision Nanosystems, Inc. (PNI), a global leader in technologies and solutions in genetic medicine, announced today that it has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and Economic Development's (ISED) Strategic Innovation Fund (SIF) to develop a COVID-19 vaccine
-
PNI will handle development of the vaccine and CanSinoBIO will take care of preclinical testing, human clinical trials, regulatory submissions and commercialization.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 21, 2020.
-
CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
5/20/2020
Precision NanoSystems to Prese CanSinoBIO will license in Precision NanoSystems' proprietary RNA vaccine platform technology Precision NanoSystems will lead RNA vaccine formulation development CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials TIANJIN, China and VANCOUVER , May 20, 2020 /PRNewswire/ - CanSino Biologics Inc. (Ca
-
Precision NanoSystems and Entos Pharmaceuticals sign license agreement for the use of the NanoAssemblr platform for scale-up and GMP manufacturing of nanomedicines
11/13/2018
Precision NanoSystems, Inc. (PNI) and Entos Pharmaceuticals (Entos) today announced they have entered into a license and supply agreement whereby PNI will provide its scale-up system, technology transfer and support the GMP manufacturing of Entos' lead candidate.
-
Precision NanoSystems Announces Manufacturing Collaboration Agreement with Ajinomoto Bio-Pharma Services for GMP Manufacturing of High Quality Nanomedicines
10/23/2018
Precision Nanosystems Inc. (PNI), a global leader in innovative solutions for the discovery, development and manufacture of novel nanoparticles medicines, announced today that it has entered into a manufacturing collaboration agreement with Ajinomoto Bio-Pharma Services
-
Precision NanoSystems raises US$6 Million to Accelerate Product Innovation and Global Expansion
6/7/2018
Precision NanoSystems (PNI) announced that it has closed a US$6M Series B investment.
-
Precision NanoSystems Announces Collaboration Agreement with Evonik Canada for the Manufacturing of High Quality Nanomedicines
6/1/2018
Precision Nanosystems Inc. (PNI), announced that they have entered into a manufacturing collaboration agreement with Evonik Canada.
-
CEO & Co-Founder Presenting at the Bloom Burton & Co. Healthcare Investor Conference
4/30/2018
Learn how PNI is leading the charge in providing an accessible solution for the discovery and development of molecularly tailored & targeted medicines at the upcoming Bloom Burton & Co. Healthcare Investor Conference scheduled for Wednesday, May 2 - Thursday, May 3, 2018.
-
Precision NanoSystems Technology Included in Newly Opened Non-Coding RNA Precision Diagnostics and Therapeutics Core Facility
1/24/2018
This new facility is dedicated to the study of ncRNA, which play an important role in regulating gene expression and are important for understanding, detecting, and treating disease.
-
Precision NanoSystems Named as One of British Columbia’s Fastest Growing Companies
12/20/2017
Precision NanoSystems is one of the fastest growing businesses in British Columbia (BC) according to the recently published Top 100 fastest-growing companies in BC list from business news journal Business in Vancouver (BIV).
-
Precision NanoSystems Named as One of British Columbia's Fastest Growing Companies
12/20/2017
Precision NanoSystems is one of the fastest growing businesses in British Columbia according to the recently published Top 100 fastest-growing companies in BC list from business news journal Business in Vancouver.
-
Precision NanoSystems To Host Nanomedicines Symposium
7/11/2017
-
Precision NanoSystems @ The BIO International Convention 2017
6/13/2017